Genetically modified sendai virus for treatment of tumours

The present invention relates to a genetically modified paramyxovirus, to a pharmaceutical composition comprising this paramyxovirus, to the use of a genetically modified paramyxovirus for therapeutic and/or prophylactic treatment of a tumour, and to a process for producing a pharmaceutical composit...

Full description

Saved in:
Bibliographic Details
Main Authors BOSSOW SASCHA, LAUER ULRICH MANFRED, ARMEANU-EBINGER SORIN, ZIMMERMANN MARTINA, BITZER MICHAEL, NEUBERT WOLFGANG
Format Patent
LanguageChinese
English
Published 03.04.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to a genetically modified paramyxovirus, to a pharmaceutical composition comprising this paramyxovirus, to the use of a genetically modified paramyxovirus for therapeutic and/or prophylactic treatment of a tumour, and to a process for producing a pharmaceutical composition for therapeutic and/or prophylactic treatment of a tumour.
Bibliography:Application Number: CN201180029278